Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Current Drug Targets|March 5, 2010
Obesity and inflammation--targets for OA therapyF Iannone, G Lapadula
Clinical and Experimental Rheumatology|May 18, 2005
Repeated infusions of low-dose infliximab plus methotrexate in psoriatic arthritis: immediate benefits are not maintained after discontinuation of infliximabM Covelli, C Scioscia, F Iannone, et al.
Reumatismo|November 8, 2014
Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathiesA Notarnicola, G Lapadula, D Natuzzi, et al.
Clinical and Experimental Rheumatology|September 1, 1995
Interleukin-10 in rheumatoid arthritisG Lapadula, F Iannone, F Dell'Accio, et al.
Reumatismo|January 12, 2005
[Sarcoidosis presenting with Raynaud's syndrome: a case report]A Nigro, F Iannone, V Grattagliano, et al.
European Journal of Clinical Investigation|August 22, 2006
Clinical outcomes of bosentan in pulmonary arterial hypertension do not correlate with levels of TIMPsG Giannelli, F Iannone, F Marinosci, et al.
Reumatismo|August 9, 2002
[Association of systemic sclerosis and psoriatic arthritis: a case report]S. Bellissimo, F. Iannone, A. Musio, et al.
Clinical and Experimental Rheumatology|September 1, 1992
Anti-enterobacteria antibodies in psoriatic arthritisG Lapadula, F Iannone, M Covelli, et al.
Reumatismo|April 8, 2014
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapyA Notarnicola, F Iannone, G Lopalco, et al.
Scandinavian Journal of Rheumatology|September 21, 2012
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapyF Iannone, R Fanizzi, C Scioscia, et al.
Pageof 12